Home / Market News / $DTSS

$DTSS news and market catalysts

The 5 most recent market catalysts affecting $DTSS, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.

5 catalysts 0 high impact 3 bullish 0 bearish Technology
Sep 17, 2026 Corporate Catalyst Bullish Impact 75
Datasea Intelligent Technology shares are trading higher after the company announced its Chinese operating entities have recently entered into AI agent digital marketing service cooperation agreements and pre-order arrangements with five customers.
This headline is a significant corporate catalyst for Datasea Intelligent Technology (DTSS). The announcement of AI agent digital marketing service cooperation agreements and pre-o…
Sep 17, 2026 Corporate Catalyst Neutral Impact 55
Datasea Announces AI Agent Marketing Agreements With Five Customers, About $1.10M Delivered To Date; Says Pre-Orders Are Not Commitments Or Backlog
This headline is a corporate catalyst for Datasea, indicating progress in its AI agent marketing segment. The $1.10M delivered revenue is a tangible positive, suggesting execution …
Sep 17, 2026 Market Technicals Bullish Impact 65
Datasea Intelligent Technology Stock Jumps Over 45% Overnight: Here's What We Know
Datasea Intelligent Technology (DTSS) saw its stock price jump over 45% in overnight trading, accompanied by trading volume approximately 180 times its average. This sharp move occ…
Sep 16, 2026 Corporate Catalyst Bullish Impact 65
Datasea Announces Chinese Operating Entity Plans To Expand Cooperation With Nanjing Linghang Intelligent Aviation To Jointly Develop AI Elderly Care Robots
This headline indicates a strategic move by Datasea to enter the burgeoning AI elderly care market through a collaboration with Nanjing Linghang Intelligent Aviation. This partners…
Aug 11, 2026 Corporate Catalyst Neutral Impact 65
Datasea Says VIE Shuhai Jingwei Completed FDA Establishment Registration And Device Listing For NeuroVibe NV-02, NV-03 As Class II 510(k)-Exempt Biofeedback Devices; Says Listing Is Not FDA Approval Or Clearance
This headline signals a positive development for Datasea, as the FDA establishment registration and device listing are necessary steps for commercialization. While not full FDA app…
 Join the waitlist for full signal validation →

New to reading filings? What an SEC 8-K is and why it moves prices

Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.